Published Date: 24 Apr 2023
China: A recent study revealed a concerning connection between hyperuricemia (HUA) and, which was published in Frontiers in Cardiovascular Medicine.
Read Full NewsAccurate and Timely Diagnosis of Endometriosis
Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors
Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity
From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes
Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities
"It really pays to be very, very, very skeptical," says one expert
Experts call for better guidance on levothyroxine initiation, deprescribing
1.
Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma
2.
Intractable cancers may respond better to treatment when using new radiation and high-performance computing.
3.
Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma
4.
A Texas study found that the majority of pancreatic cancer patients do not receive life-saving surgery.
5.
Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes
1.
Understanding Thrombin Time: What It Is and How It Can Help Diagnose Blood Clotting Disorders
2.
Unveiling Tumor Immunity: Pan-Cancer Proteogenomics Characterization
3.
Exploring Innovative Solutions for Infantile Hemangioma Treatment
4.
Unveiling the Mystery of Echinocyte: A Closer Look at the Unique Red Blood Cell
5.
Stomach Cancer: Uncovering the Subtle Signs and Symptoms
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
2.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
3.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
4.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
5.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation